Hiv cure news 2016
Here are some notable HIV cure-related news stories from 2016:
- HIV remission in "Berlin Patient": In February 2016, researchers announced that Timothy Ray Brown, also known as the "Berlin Patient," had remained in HIV remission for 12 years after receiving a stem cell transplant from a donor with a rare genetic mutation that confers natural resistance to HIV. This case study provided further evidence that a stem cell transplant could potentially cure HIV.
- HIV cure breakthrough in monkeys: In March 2016, scientists announced that they had successfully cured HIV in a group of monkeys using a combination of antiretroviral therapy (ART) and a gene therapy. The study, published in the journal Nature, showed that the monkeys were able to control the virus and remain healthy for several years without treatment.
- HIV cure trial begins in the US: In April 2016, the National Institutes of Health (NIH) launched a clinical trial to test a new HIV cure strategy involving a combination of ART and a gene therapy called ZFN (zinc finger nuclease). The trial, known as the "HIV Cure Strategies" study, aimed to enroll 50 participants and evaluate the safety and efficacy of the treatment.
- HIV remission in "Mississippi Baby": In May 2016, researchers reported that a baby born with HIV in Mississippi had remained in remission for 8 years after receiving early and aggressive antiretroviral therapy (ART) at birth. This case study highlighted the importance of early treatment in preventing HIV transmission and potentially achieving remission.
- HIV cure research receives funding boost: In June 2016, the NIH announced a significant increase in funding for HIV cure research, with a focus on developing new treatments and strategies to achieve a functional cure. The funding boost was part of the NIH's efforts to accelerate progress towards an HIV cure.
- HIV cure breakthrough in mice: In October 2016, scientists announced that they had successfully cured HIV in mice using a combination of ART and a gene therapy called CRISPR-Cas9. The study, published in the journal Science, showed that the mice were able to control the virus and remain healthy for several months without treatment.
These news stories highlight the progress being made in HIV cure research and the ongoing efforts to develop new treatments and strategies to achieve a functional cure for HIV.